Total Funding
19
Total FundingSeed raised
Growth Score in past quarter
pts
Heat Score 19 in past quarter
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Epitech is developing a Breakthrough Treatment For Dry Eye Syndrome.
- Itzik Ronen: Co-founder and CEO
- Tomer Carmeli: Vice President of Research and Development
About the Company
Epitech is a developer of non-invasive ocular neurostimulation therapy, designed to treat the entire ocular surface and tear film, for long-lasting relief of dry eye symptoms. Its proprietary technology is based on neurostimulation by targeted magnetic fields, resulting in the reinforcement of the structural integrity of the ocular surface.
Epitech the company was founded in 2015 and is based in Yokneam Illit, Israel.

